Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 12 | 2025 | 1675 | 1.890 |
Why?
|
| Lung Neoplasms | 11 | 2025 | 1605 | 1.650 |
Why?
|
| Multifactorial Inheritance | 4 | 2025 | 139 | 1.260 |
Why?
|
| Linkage Disequilibrium | 5 | 2024 | 309 | 1.040 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2025 | 3143 | 0.940 |
Why?
|
| Smoking | 6 | 2025 | 1044 | 0.440 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2025 | 2626 | 0.430 |
Why?
|
| Genes, Essential | 1 | 2009 | 41 | 0.330 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2014 | 1899 | 0.320 |
Why?
|
| Prostatic Neoplasms | 4 | 2012 | 1549 | 0.290 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2023 | 83 | 0.240 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2025 | 313 | 0.220 |
Why?
|
| Research Personnel | 1 | 2024 | 118 | 0.220 |
Why?
|
| Population Health | 1 | 2023 | 37 | 0.200 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2025 | 188 | 0.200 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2023 | 57 | 0.200 |
Why?
|
| Risk Factors | 5 | 2025 | 10272 | 0.200 |
Why?
|
| Patient Acuity | 1 | 2022 | 64 | 0.190 |
Why?
|
| Phenotype | 5 | 2024 | 4260 | 0.190 |
Why?
|
| Humans | 25 | 2025 | 124802 | 0.180 |
Why?
|
| Quantitative Trait Loci | 1 | 2022 | 284 | 0.180 |
Why?
|
| Crohn Disease | 1 | 2024 | 284 | 0.180 |
Why?
|
| Dyspnea | 1 | 2022 | 151 | 0.180 |
Why?
|
| Regression Analysis | 1 | 2022 | 778 | 0.170 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 333 | 0.170 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 361 | 0.160 |
Why?
|
| Thoracic Surgery | 1 | 2021 | 158 | 0.160 |
Why?
|
| Body Mass Index | 2 | 2022 | 1568 | 0.160 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2025 | 848 | 0.150 |
Why?
|
| Genetic Testing | 1 | 2025 | 1004 | 0.150 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 577 | 0.150 |
Why?
|
| Carcinogenesis | 1 | 2021 | 333 | 0.150 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2023 | 662 | 0.150 |
Why?
|
| Liver Neoplasms | 2 | 2025 | 1319 | 0.140 |
Why?
|
| Adenocarcinoma | 1 | 2024 | 998 | 0.140 |
Why?
|
| Kidney Diseases | 1 | 2021 | 481 | 0.130 |
Why?
|
| Glioma | 1 | 2021 | 497 | 0.130 |
Why?
|
| Male | 13 | 2025 | 61302 | 0.130 |
Why?
|
| Case-Control Studies | 4 | 2024 | 3288 | 0.130 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2024 | 938 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 2060 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 872 | 0.110 |
Why?
|
| United Kingdom | 2 | 2024 | 192 | 0.100 |
Why?
|
| Female | 9 | 2025 | 66575 | 0.100 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 1111 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 1019 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 1812 | 0.080 |
Why?
|
| Neoplasms | 2 | 2014 | 2789 | 0.080 |
Why?
|
| United States | 4 | 2025 | 10875 | 0.070 |
Why?
|
| Genome, Human | 2 | 2014 | 1273 | 0.070 |
Why?
|
| Neoplasm Metastasis | 2 | 2025 | 670 | 0.070 |
Why?
|
| Genomics | 1 | 2014 | 1490 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2012 | 1493 | 0.060 |
Why?
|
| Smokers | 1 | 2024 | 39 | 0.060 |
Why?
|
| North America | 1 | 2024 | 239 | 0.050 |
Why?
|
| Interferon Regulatory Factors | 1 | 2023 | 38 | 0.050 |
Why?
|
| Adult | 4 | 2025 | 29482 | 0.050 |
Why?
|
| Aged | 3 | 2025 | 19693 | 0.050 |
Why?
|
| Genetic Loci | 1 | 2024 | 339 | 0.050 |
Why?
|
| International Agencies | 1 | 2021 | 29 | 0.050 |
Why?
|
| Colitis, Ulcerative | 1 | 2024 | 208 | 0.050 |
Why?
|
| Risk | 1 | 2023 | 757 | 0.050 |
Why?
|
| Education | 1 | 2021 | 107 | 0.040 |
Why?
|
| Middle Aged | 3 | 2025 | 26727 | 0.040 |
Why?
|
| Gene Expression Profiling | 3 | 2012 | 1699 | 0.040 |
Why?
|
| Morbidity | 1 | 2021 | 244 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2023 | 621 | 0.040 |
Why?
|
| Research Design | 1 | 2024 | 690 | 0.040 |
Why?
|
| Computational Biology | 1 | 2024 | 821 | 0.040 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 138 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2021 | 473 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2021 | 344 | 0.040 |
Why?
|
| Life Style | 1 | 2021 | 414 | 0.040 |
Why?
|
| Comorbidity | 1 | 2023 | 1532 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2021 | 775 | 0.030 |
Why?
|
| Length of Stay | 1 | 2021 | 1309 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2819 | 0.030 |
Why?
|
| Lung | 1 | 2022 | 1492 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3447 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2023 | 4786 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2014 | 644 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 3728 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 400 | 0.020 |
Why?
|
| Mutation | 1 | 2024 | 5814 | 0.020 |
Why?
|
| Logistic Models | 1 | 2014 | 1810 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2021 | 3067 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2010 | 471 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 430 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 1473 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 1616 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 16290 | 0.010 |
Why?
|
| Child | 1 | 2021 | 24456 | 0.010 |
Why?
|